Bcl-2 Inhibition to Overcome Memory Cell Barriers in Transplantation

被引:15
作者
Cippa, P. E. [1 ,2 ]
Gabriel, S. S. [1 ,2 ]
Kraus, A. K. [1 ,2 ]
Chen, J. [1 ,2 ]
Wekerle, T. [3 ]
Guimezanes, A. [4 ]
Wuethrich, R. P. [1 ,2 ]
Fehr, T. [1 ,2 ]
机构
[1] Univ Zurich, Inst Physiol, Zurich, Switzerland
[2] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland
[3] Med Univ Vienna, Dept Surg, Vienna, Austria
[4] Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France
基金
瑞士国家科学基金会;
关键词
ABT-737; apoptosis; Bcl-2; memory T cells; tolerance; transplantation; T-CELLS; ALLOGRAFT SURVIVAL; MIXED CHIMERISM; CD8; DEPENDENCE; MICE; TOLERANCE; ANTIBODY; ABT-737; DIFFERENTIATION; LYMPHOCYTES;
D O I
10.1111/ajt.12554
中图分类号
R61 [外科手术学];
学科分类号
摘要
Memory T cells (Tm) represent a major barrier for immunosuppression and tolerance induction after solid organ transplantation. Taking into consideration the critical role of the intrinsic apoptosis pathway in the generation and maintenance of Tm, we developed a new concept to deplete alloreactive Tm by targeting Bcl-2 proteins. The small-molecule Bcl-2/Bcl-XL inhibitor ABT-737 efficiently induced apoptosis in alloreactive Tm in vitro and in vivo and prolonged skin graft survival in sensitized recipients. A short course of ABT-737 induction therapy prevented Tm-mediated resistance in a donor-specific transfusion model and allowed mixed chimerism induction across Tm barriers. Since Bcl-2 inhibitors yielded encouraging safety results in cancer trials, this novel approach might represent a substantial advance to prevent allograft rejection and induce tolerance in sensitized recipients.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 35 条
[21]   Immunosenescence: what does it mean to health outcomes in older adults? [J].
McElhaney, Janet E. ;
Effros, Rita B. .
CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (04) :418-424
[22]   Host Alloreactive Memory T Cells Influence Tolerance to Kidney Allografts in Nonhuman Primates [J].
Nadazdin, Ognjenka ;
Boskovic, Svjetlan ;
Murakami, Toru ;
Tocco, Georges ;
Smith, Rex-Neal ;
Colvin, Robert B. ;
Sachs, David H. ;
Allan, James ;
Madsen, Joren C. ;
Kawai, Tatsuo ;
Cosimi, A. Benedict ;
Benichou, Gilles .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (86)
[23]   An inhibitor of Bcl-2 family proteins induces regression of solid tumours [J].
Oltersdorf, T ;
Elmore, SW ;
Shoemaker, AR ;
Armstrong, RC ;
Augeri, DJ ;
Belli, BA ;
Bruncko, M ;
Deckwerth, TL ;
Dinges, J ;
Hajduk, PJ ;
Joseph, MK ;
Kitada, S ;
Korsmeyer, SJ ;
Kunzer, AR ;
Letai, A ;
Li, C ;
Mitten, MJ ;
Nettesheim, DG ;
Ng, S ;
Nimmer, PM ;
O'Connor, JM ;
Oleksijew, A ;
Petros, AM ;
Reed, JC ;
Shen, W ;
Tahir, SK ;
Thompson, CB ;
Tomaselli, KJ ;
Wang, BL ;
Wendt, MD ;
Zhang, HC ;
Fesik, SW ;
Rosenberg, SH .
NATURE, 2005, 435 (7042) :677-681
[24]   Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion [J].
Pearl, JP ;
Parris, J ;
Hale, DA ;
Hoffmann, SC ;
Bernstein, WB ;
McCoy, KL ;
Swanson, SJ ;
Mannon, RB ;
Roederer, M ;
Kirk, AD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) :465-474
[25]   Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim [J].
Pellegrini, M ;
Belz, G ;
Bouillet, P ;
Strasser, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14175-14180
[26]   Transplantation tolerance through mixed chimerism [J].
Pilat, Nina ;
Wekerle, Thomas .
NATURE REVIEWS NEPHROLOGY, 2010, 6 (10) :594-605
[27]   A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival [J].
Sabbagh, Laurent ;
Srokowski, Cathy C. ;
Pulle, Gayle ;
Snell, Laura M. ;
Sedgmen, Bradley J. ;
Liu, Yuanqing ;
Tsitsikov, Erdyni N. ;
Watts, Tania H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (49) :18703-18708
[28]   Induced Immune Tolerance for Kidney Transplantation [J].
Scandling, John D. ;
Busque, Stephan ;
Shizuru, Judith A. ;
Engleman, Edgar G. ;
Strober, Samuel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14) :1359-1360
[29]   ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor [J].
Tse, Christin ;
Shoemaker, Alexander R. ;
Adickes, Jessica ;
Anderson, Mark G. ;
Chen, Jun ;
Jin, Sha ;
Johnson, Eric F. ;
Marsh, Kerman C. ;
Mitten, Michael J. ;
Nimmer, Paul ;
Roberts, Lisa ;
Tahir, Stephen K. ;
Mao, Yu ;
Yang, Xiufen ;
Zhang, Haichao ;
Fesik, Stephen ;
Rosenberg, Saul H. ;
Elmore, Steven W. .
CANCER RESEARCH, 2008, 68 (09) :3421-3428
[30]   Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates [J].
Weaver, Tim A. ;
Charafeddine, Ali H. ;
Agarwal, Avinash ;
Turner, Alexandra P. ;
Russell, Maria ;
Leopardi, Frank V. ;
Kampen, Robert L. ;
Stempora, Linda ;
Song, Mingqing ;
Larsen, Christian P. ;
Kirk, Allan D. .
NATURE MEDICINE, 2009, 15 (07) :746-749